semaglutide & tirzepatide stafford and are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Semaglutide vs Tirzepatide: Which GLP-1

doi: 10.1002/cam4.1670 100 KaoJ-KWangSCHoLWHuangSWLeeCHLeeMSet al

Unlike its single-pathway predecessors, tirzepatide dual-action mechanisms tackle weight loss by reducing appetite, slowing digestion, and increasing insulin sensitivity

The gestational diabetes and hypertensive disorders of pregnancy composites as well as gestational hypertension continued to be significantly decreased even at prescriptions within 6 and 3 months of pregnancy, the researchers wrote

Retatrutide synthesis is non-trivial

For a broader comparison of approved and research-stage weight loss peptides, see our best peptides for weight loss guide